Duloxetine delayed-release capsules recalled for manufacturing impurity exceeding limits
Breckenridge Pharmaceutical recalls Duloxetine 20 mg capsules nationwide after detecting N-nitroso-duloxetine impurity above FDA-recommended limits in approximately 7,188 units from lot 220456, expiring February 2025.
- Product
- DULOXETINE — DULOXETINE (DULOXETINE HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide